Real-time enrollment status for this beta-thalassemia clinical trial
Current Status
Recruiting
Checked: August 27, 2026 at 10:40 PM UTC
| NCT Number | NCT04143724 |
| Recruiting Status | Recruiting |
| Condition | Beta-Thalassemia |
| Phase | PHASE2 |
| Target Enrollment | 99 participants |
| Active Locations | 2 sites in the US |
| Sponsor | Celgene |
| Last Updated on CT.gov | July 10, 2026 (Jul 10, 2026) |
As of August 27, 2026: Clinical trial NCT04143724 is currently recruiting participants. This phase2 study for beta-thalassemia is actively seeking new participants at 2 locations across the United States. The study is sponsored by Celgene. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT04143724 is actively recruiting participants as of August 27, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 2 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT04143724 was last updated Jul 10, 2026 (July 10, 2026). HelloStudys verifies this status automatically.